Concepedia

Publication | Open Access

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients

DOIFull Paper Access

12

Citations

17

References

2022

Year

Kohei Kushiro, Satoshi Watanabe, Yuka Goto, Toshiya Fujisaki, Naohiro Yanagimura, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Tomohiro Tanaka, Yu Saida,
Translational Lung Cancer Research

Abstract

AMR after chemoimmunotherapy shows good clinical efficacy and safety in patients with recurrent SCLC.

References

YearCitations

Page 1